Clinical Chemistry
Biomarker Detects Early Alzheimer’s Disease
In Alzheimer disease (AD), abnormal metabolism of amyloid-β (Aβ) and tau leads to accumulation of extracellular plaques formed by misfolded Aβ and intraneuronal neurofibrillary...
Product Showcase
NGS SYSTEM
The Ion GeneStudio S5 systems are designed to enable a broad range of targeted next-generation sequencing (NGS) appli... Read more...
IMMUNOASSAY KIT
SNIBE’s Immunoassay Kit offers the broadest CLIA test menu with 163 assays and on board stability 24/7 during four we... Read more...
HEMATOLOGY ANALYZER
The Elite 580 features ‘walkaway’ analysis for 60 samples and a responsive 22-inch color touchscreen, reporting 29 pa... Read more...
CEPHALOSPORINS RESISTANCE TEST
The MBT STAR-Cepha IVD Assay detects resistances towards 3rd generation cephalosporins within just one hour after a p... Read more...
MICROPLATE READER
The DIAWasher ELX5O/8 absorbance microplate reader offers buffer selection with automatic switching for up to three w... Read more...
Latest Clinical Chemistry News
- Elevated Fructosamine Levels Associated with Increased PJI Risk
- Biomarkers Predict Whether RA Patients Will Respond to DMARDs
- Breath Ammonia Biomarker Predicts Kidney Function in CKD Patients
- Metabolomics Profiles Associated with Diabetic Retinopathy
- High-Sensitivity C-Reactive Protein Investigated in Acute Myocardial Infarction Patients